ArticleJournal of clinical laboratory analysis2026
RETRACTION: Guanylate-Binding Protein 1 Correlates With Advanced Tumor Features and Serves as a Prognostic Biomarker for Worse Survival in Lung Adenocarcinoma Patients.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionQ. Wan, J. Qu, L. Li, F. Gao, "Guanylate-Binding Protein 1 Correlates With Advanced Tumor Features and Serves as a Prognostic Biomarker for Worse Survival in Lung Adenocarcinoma Patients," Journal of Clinical and Laboratory Analysis 35, no. 2 (2020): e23610, https://doi.org/10.1002/jcla.23610. The above article, published online on 10 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Rong Fu; and Wiley Periodicals, LLC. The retraction has been agreed due to concerns raised by a third party, which identified compromised data and systematic issues in the published article, and several flaws and inconsistencies between results presented and experimental methods described were found. Furthermore, several claims lack sufficient support from literature. The authors and their institutes were unresponsive when these concerns were brought to their attention. Accordingly, the article is retracted as the editors have lost trust in the reliability of the data and the results presented.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.